Global and United States Transmucosal Drug Delivery Devices Market Insights, Forecast to 2027

Publisher Name :
Date: 07-Dec-2021
No. of pages: 139
Inquire Before Buying

Transmucosal Drug Delivery Devices market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Transmucosal Drug Delivery Devices market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.

For United States market, this report focuses on the Transmucosal Drug Delivery Devices market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in United States.

Segment by Type

- Buccal Route

- Rectal Route

- Nasal Route

Segment by Application

- Hospital

- Residential

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - U.A.E

By Company

- Allergan

- Amphastar Pharmaceuticals Inc

- Aquestive Therapeutics Inc

- ARS Pharmaceuticals

- Combinent BioMedical Systems Inc

- Aegis Therapeutics LLC

- Bespak Europe Ltd

- Callitas Therapeutics Inc

Global and United States Transmucosal Drug Delivery Devices Market Insights, Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Transmucosal Drug Delivery Devices Product Introduction
1.2 Market by Type
1.2.1 Global Transmucosal Drug Delivery Devices Market Size Growth Rate by Type
1.2.2 Buccal Route
1.2.3 Rectal Route
1.2.4 Nasal Route
1.3 Market by Application
1.3.1 Global Transmucosal Drug Delivery Devices Market Size Growth Rate by Application
1.3.2 Hospital
1.3.3 Residential
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Transmucosal Drug Delivery Devices Market Size, Estimates and Forecasts
2.1.1 Global Transmucosal Drug Delivery Devices Revenue 2016-2027
2.1.2 Global Transmucosal Drug Delivery Devices Sales 2016-2027
2.2 Global Transmucosal Drug Delivery Devices, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Transmucosal Drug Delivery Devices Historical Market Size by Region (2016-2021)
2.3.1 Global Transmucosal Drug Delivery Devices Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Transmucosal Drug Delivery Devices Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Transmucosal Drug Delivery Devices Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Transmucosal Drug Delivery Devices Sales Forecast by Region (2022-2027)
2.4.2 Global Transmucosal Drug Delivery Devices Revenue Forecast by Region (2022-2027)
3 Global Transmucosal Drug Delivery Devices Competitor Landscape by Players
3.1 Global Top Transmucosal Drug Delivery Devices Manufacturers by Sales
3.1.1 Global Transmucosal Drug Delivery Devices Sales by Manufacturer (2016-2021)
3.1.2 Global Transmucosal Drug Delivery Devices Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Transmucosal Drug Delivery Devices Manufacturers by Revenue
3.2.1 Key Transmucosal Drug Delivery Devices Manufacturers Covered: Ranking by Revenue
3.2.2 Global Transmucosal Drug Delivery Devices Revenue by Manufacturers (2016-2021)
3.2.3 Global Transmucosal Drug Delivery Devices Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Transmucosal Drug Delivery Devices Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Transmucosal Drug Delivery Devices Revenue in 2020
3.2.6 Global Transmucosal Drug Delivery Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Transmucosal Drug Delivery Devices Price by Manufacturers
3.4 Global Transmucosal Drug Delivery Devices Manufacturing Base Distribution, Product Types
3.4.1 Transmucosal Drug Delivery Devices Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Transmucosal Drug Delivery Devices Product Type
3.4.3 Date of International Manufacturers Enter into Transmucosal Drug Delivery Devices Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Transmucosal Drug Delivery Devices Market Size by Type (2016-2021)
4.1.1 Global Transmucosal Drug Delivery Devices Sales by Type (2016-2021)
4.1.2 Global Transmucosal Drug Delivery Devices Revenue by Type (2016-2021)
4.1.3 Transmucosal Drug Delivery Devices Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Transmucosal Drug Delivery Devices Market Size Forecast by Type (2022-2027)
4.2.1 Global Transmucosal Drug Delivery Devices Sales Forecast by Type (2022-2027)
4.2.2 Global Transmucosal Drug Delivery Devices Revenue Forecast by Type (2022-2027)
4.2.3 Transmucosal Drug Delivery Devices Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Transmucosal Drug Delivery Devices Market Size by Application (2016-2021)
5.1.1 Global Transmucosal Drug Delivery Devices Sales by Application (2016-2021)
5.1.2 Global Transmucosal Drug Delivery Devices Revenue by Application (2016-2021)
5.1.3 Transmucosal Drug Delivery Devices Price by Application (2016-2021)
5.2 Transmucosal Drug Delivery Devices Market Size Forecast by Application (2022-2027)
5.2.1 Global Transmucosal Drug Delivery Devices Sales Forecast by Application (2022-2027)
5.2.2 Global Transmucosal Drug Delivery Devices Revenue Forecast by Application (2022-2027)
5.2.3 Global Transmucosal Drug Delivery Devices Price Forecast by Application (2022-2027)
6 United States by Players, Type and Application
6.1 United States Transmucosal Drug Delivery Devices Market Size YoY Growth 2016-2027
6.1.1 United States Transmucosal Drug Delivery Devices Sales YoY Growth 2016-2027
6.1.2 United States Transmucosal Drug Delivery Devices Revenue YoY Growth 2016-2027
6.1.3 United States Transmucosal Drug Delivery Devices Market Share in Global Market 2016-2027
6.2 United States Transmucosal Drug Delivery Devices Market Size by Players (International and Local Players)
6.2.1 United States Top Transmucosal Drug Delivery Devices Players by Sales (2016-2021)
6.2.2 United States Top Transmucosal Drug Delivery Devices Players by Revenue (2016-2021)
6.3 United States Transmucosal Drug Delivery Devices Historic Market Review by Type (2016-2021)
6.3.1 United States Transmucosal Drug Delivery Devices Sales Market Share by Type (2016-2021)
6.3.2 United States Transmucosal Drug Delivery Devices Revenue Market Share by Type (2016-2021)
6.3.3 United States Transmucosal Drug Delivery Devices Price by Type (2016-2021)
6.4 United States Transmucosal Drug Delivery Devices Market Estimates and Forecasts by Type (2022-2027)
6.4.1 United States Transmucosal Drug Delivery Devices Sales Forecast by Type (2022-2027)
6.4.2 United States Transmucosal Drug Delivery Devices Revenue Forecast by Type (2022-2027)
6.4.3 United States Transmucosal Drug Delivery Devices Price Forecast by Type (2022-2027)
6.5 United States Transmucosal Drug Delivery Devices Historic Market Review by Application (2016-2021)
6.5.1 United States Transmucosal Drug Delivery Devices Sales Market Share by Application (2016-2021)
6.5.2 United States Transmucosal Drug Delivery Devices Revenue Market Share by Application (2016-2021)
6.5.3 United States Transmucosal Drug Delivery Devices Price by Application (2016-2021)
6.6 United States Transmucosal Drug Delivery Devices Market Estimates and Forecasts by Application (2022-2027)
6.6.1 United States Transmucosal Drug Delivery Devices Sales Forecast by Application (2022-2027)
6.6.2 United States Transmucosal Drug Delivery Devices Revenue Forecast by Application (2022-2027)
6.6.3 United States Transmucosal Drug Delivery Devices Price Forecast by Application (2022-2027)
7 North America
7.1 North America Transmucosal Drug Delivery Devices Market Size YoY Growth 2016-2027
7.2 North America Transmucosal Drug Delivery Devices Market Facts & Figures by Country
7.2.1 North America Transmucosal Drug Delivery Devices Sales by Country (2016-2021)
7.2.2 North America Transmucosal Drug Delivery Devices Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Transmucosal Drug Delivery Devices Market Size YoY Growth 2016-2027
8.2 Asia Pacific Transmucosal Drug Delivery Devices Market Facts & Figures by Region
8.2.1 Asia Pacific Transmucosal Drug Delivery Devices Sales by Region (2016-2021)
8.2.2 Asia Pacific Transmucosal Drug Delivery Devices Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Transmucosal Drug Delivery Devices Market Size YoY Growth 2016-2027
9.2 Europe Transmucosal Drug Delivery Devices Market Facts & Figures by Country
9.2.1 Europe Transmucosal Drug Delivery Devices Sales by Country (2016-2021)
9.2.2 Europe Transmucosal Drug Delivery Devices Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Transmucosal Drug Delivery Devices Market Size YoY Growth 2016-2027
10.2 Latin America Transmucosal Drug Delivery Devices Market Facts & Figures by Country
10.2.1 Latin America Transmucosal Drug Delivery Devices Sales by Country (2016-2021)
10.2.2 Latin America Transmucosal Drug Delivery Devices Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Transmucosal Drug Delivery Devices Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Transmucosal Drug Delivery Devices Market Facts & Figures by Country
11.2.1 Middle East and Africa Transmucosal Drug Delivery Devices Sales by Country (2016-2021)
11.2.2 Middle East and Africa Transmucosal Drug Delivery Devices Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Allergan
12.1.1 Allergan Corporation Information
12.1.2 Allergan Description and Business Overview
12.1.3 Allergan Transmucosal Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Allergan Transmucosal Drug Delivery Devices Products Offered
12.1.5 Allergan Recent Development
12.2 Amphastar Pharmaceuticals Inc
12.2.1 Amphastar Pharmaceuticals Inc Corporation Information
12.2.2 Amphastar Pharmaceuticals Inc Description and Business Overview
12.2.3 Amphastar Pharmaceuticals Inc Transmucosal Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Amphastar Pharmaceuticals Inc Transmucosal Drug Delivery Devices Products Offered
12.2.5 Amphastar Pharmaceuticals Inc Recent Development
12.3 Aquestive Therapeutics Inc
12.3.1 Aquestive Therapeutics Inc Corporation Information
12.3.2 Aquestive Therapeutics Inc Description and Business Overview
12.3.3 Aquestive Therapeutics Inc Transmucosal Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Aquestive Therapeutics Inc Transmucosal Drug Delivery Devices Products Offered
12.3.5 Aquestive Therapeutics Inc Recent Development
12.4 ARS Pharmaceuticals
12.4.1 ARS Pharmaceuticals Corporation Information
12.4.2 ARS Pharmaceuticals Description and Business Overview
12.4.3 ARS Pharmaceuticals Transmucosal Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
12.4.4 ARS Pharmaceuticals Transmucosal Drug Delivery Devices Products Offered
12.4.5 ARS Pharmaceuticals Recent Development
12.5 Combinent BioMedical Systems Inc
12.5.1 Combinent BioMedical Systems Inc Corporation Information
12.5.2 Combinent BioMedical Systems Inc Description and Business Overview
12.5.3 Combinent BioMedical Systems Inc Transmucosal Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Combinent BioMedical Systems Inc Transmucosal Drug Delivery Devices Products Offered
12.5.5 Combinent BioMedical Systems Inc Recent Development
12.6 Aegis Therapeutics LLC
12.6.1 Aegis Therapeutics LLC Corporation Information
12.6.2 Aegis Therapeutics LLC Description and Business Overview
12.6.3 Aegis Therapeutics LLC Transmucosal Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Aegis Therapeutics LLC Transmucosal Drug Delivery Devices Products Offered
12.6.5 Aegis Therapeutics LLC Recent Development
12.7 Bespak Europe Ltd
12.7.1 Bespak Europe Ltd Corporation Information
12.7.2 Bespak Europe Ltd Description and Business Overview
12.7.3 Bespak Europe Ltd Transmucosal Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Bespak Europe Ltd Transmucosal Drug Delivery Devices Products Offered
12.7.5 Bespak Europe Ltd Recent Development
12.8 Callitas Therapeutics Inc
12.8.1 Callitas Therapeutics Inc Corporation Information
12.8.2 Callitas Therapeutics Inc Description and Business Overview
12.8.3 Callitas Therapeutics Inc Transmucosal Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Callitas Therapeutics Inc Transmucosal Drug Delivery Devices Products Offered
12.8.5 Callitas Therapeutics Inc Recent Development
12.11 Allergan
12.11.1 Allergan Corporation Information
12.11.2 Allergan Description and Business Overview
12.11.3 Allergan Transmucosal Drug Delivery Devices Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Allergan Transmucosal Drug Delivery Devices Products Offered
12.11.5 Allergan Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Transmucosal Drug Delivery Devices Industry Trends
13.2 Transmucosal Drug Delivery Devices Market Drivers
13.3 Transmucosal Drug Delivery Devices Market Challenges
13.4 Transmucosal Drug Delivery Devices Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Transmucosal Drug Delivery Devices Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global Transmucosal Drug Delivery Devices Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Buccal Route
Table 3. Major Manufacturers of Rectal Route
Table 4. Major Manufacturers of Nasal Route
Table 5. Global Transmucosal Drug Delivery Devices Market Size Growth Rate by Application (2021-2027) & (K Units)
Table 6. Global Transmucosal Drug Delivery Devices Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027
Table 7. Global Transmucosal Drug Delivery Devices Sales by Regions (2016-2021) & (K Units)
Table 8. Global Transmucosal Drug Delivery Devices Sales Market Share by Regions (2016-2021)
Table 9. Global Transmucosal Drug Delivery Devices Revenue by Regions (2016-2021) & (US$ Million)
Table 10. Global Transmucosal Drug Delivery Devices Sales Forecast by Region (2022-2027) & (K Units)
Table 11. Global Transmucosal Drug Delivery Devices Sales Market Share Forecast by Region (2022-2027)
Table 12. Global Transmucosal Drug Delivery Devices Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 13. Global Transmucosal Drug Delivery Devices Revenue Market Share Forecast by Region (2022-2027)
Table 14. Global Transmucosal Drug Delivery Devices Sales by Manufacturers (2016-2021) (K Units)
Table 15. Global Transmucosal Drug Delivery Devices Sales Share by Manufacturers (2016-2021)
Table 16. Ranking of Global Top Transmucosal Drug Delivery Devices Manufacturers by Revenue (US$ Million) in 2020
Table 17. Transmucosal Drug Delivery Devices Revenue by Manufacturers (2016-2021) (US$ Million)
Table 18. Transmucosal Drug Delivery Devices Revenue Share by Manufacturers (2016-2021)
Table 19. Global Transmucosal Drug Delivery Devices Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 20. Global Transmucosal Drug Delivery Devices by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Transmucosal Drug Delivery Devices as of 2020)
Table 21. Key Manufacturers Transmucosal Drug Delivery Devices Price (2016-2021) (USD/Unit)
Table 22. Transmucosal Drug Delivery Devices Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Transmucosal Drug Delivery Devices Product Type
Table 24. Date of International Manufacturers Enter into Transmucosal Drug Delivery Devices Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Transmucosal Drug Delivery Devices Sales by Type (2016-2021) (K Units)
Table 27. Global Transmucosal Drug Delivery Devices Sales Share by Type (2016-2021)
Table 28. Global Transmucosal Drug Delivery Devices Revenue by Type (2016-2021) (US$ Million)
Table 29. Global Transmucosal Drug Delivery Devices Revenue Share by Type (2016-2021)
Table 30. Transmucosal Drug Delivery Devices Average Selling Price (ASP) by Type (2016-2021) & (USD/Unit)
Table 31. Global Transmucosal Drug Delivery Devices Sales Forecast by Type (2022-2027) & (K Units)
Table 32. Global Transmucosal Drug Delivery Devices Sales Market Share Forecast by Type (2022-2027)
Table 33. Global Transmucosal Drug Delivery Devices Revenue Forecast V (2022-2027) & (US$ Million)
Table 34. Global Transmucosal Drug Delivery Devices Revenue Market Share Forecast by Type (2022-2027)
Table 35. Global Transmucosal Drug Delivery Devices Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Unit)
Table 36. Global Transmucosal Drug Delivery Devices Sales by Application (2016-2021) (K Units)
Table 37. Global Transmucosal Drug Delivery Devices Sales Share by Application (2016-2021)
Table 38. Global Transmucosal Drug Delivery Devices Revenue by Application (2016-2021) (US$ Million)
Table 39. Global Transmucosal Drug Delivery Devices Revenue Share by Application (2016-2021)
Table 40. Transmucosal Drug Delivery Devices Average Selling Price (ASP) by Application (2016-2021) & (USD/Unit)
Table 41. Global Transmucosal Drug Delivery Devices Sales Forecast by Application (2022-2027) & (K Units)
Table 42. Global Transmucosal Drug Delivery Devices Sales Market Share Forecast by Application (2022-2027)
Table 43. Global Transmucosal Drug Delivery Devices Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 44. Global Transmucosal Drug Delivery Devices Revenue Market Share Forecast by Application (2022-2027)
Table 45. Global Transmucosal Drug Delivery Devices Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Unit)
Table 46. United States Transmucosal Drug Delivery Devices Sales (K Units) of Key Companies (2016-2021)
Table 47. United States Transmucosal Drug Delivery Devices Sales Share by Company (2016-2021)
Table 48. United States Transmucosal Drug Delivery Devices Revenue (US$ Million) by Company (2016-2021)
Table 49. United States Transmucosal Drug Delivery Devices Revenue Share by Company (2016-2021)
Table 50. United States Transmucosal Drug Delivery Devices Sales (K Units) by Type (2016-2021)
Table 51. United States Transmucosal Drug Delivery Devices Sales Share by Type (2016-2021)
Table 52. United States Transmucosal Drug Delivery Devices Revenue (US$ Million) Market Share by Type (2016-2021)
Table 53. United States Transmucosal Drug Delivery Devices Price (USD/Unit) by Type (2016-2021)
Table 54. United States Transmucosal Drug Delivery Devices Sales (K Units) by Type (2022-2027)
Table 55. United States Transmucosal Drug Delivery Devices Sales Share by Type (2022-2027)
Table 56. United States Transmucosal Drug Delivery Devices Revenue (US$ Million) Market Share by Type (2022-2027)
Table 57. United States Transmucosal Drug Delivery Devices Revenue Share by Type (2022-2027)
Table 58. United States Transmucosal Drug Delivery Devices Price (USD/Unit) by Type (2022-2027)
Table 59. United States Transmucosal Drug Delivery Devices Sales (K Units) by Application (2016-2021)
Table 60. United States Transmucosal Drug Delivery Devices Sales Share by Application (2016-2021)
Table 61. United States Transmucosal Drug Delivery Devices Revenue (US$ Million) Market Share by Application (2016-2021)
Table 62. United States Transmucosal Drug Delivery Devices Price (USD/Unit) by Application (2016-2021)
Table 63. United States Transmucosal Drug Delivery Devices Sales (K Units) by Application (2022-2027)
Table 64. United States Transmucosal Drug Delivery Devices Sales Share by Application (2022-2027)
Table 65. United States Transmucosal Drug Delivery Devices Revenue (US$ Million) Market Share by Application (2022-2027)
Table 66. United States Transmucosal Drug Delivery Devices Revenue Share by Application (2022-2027)
Table 67. United States Transmucosal Drug Delivery Devices Price (USD/Unit) by Application (2022-2027)
Table 68. North America Transmucosal Drug Delivery Devices Sales by Country (2016-2021) & (K Units)
Table 69. North America Transmucosal Drug Delivery Devices Sales Market Share by Country (2016-2021)
Table 70. North America Transmucosal Drug Delivery Devices Revenue by Country (2016-2021) & (US$ Million)
Table 71. North America Transmucosal Drug Delivery Devices Revenue Market Share by Country (2016-2021)
Table 72. Asia Pacific Transmucosal Drug Delivery Devices Sales by Region (2016-2021) & (K Units)
Table 73. Asia Pacific Transmucosal Drug Delivery Devices Sales Market Share by Region (2016-2021)
Table 74. Asia Pacific Transmucosal Drug Delivery Devices Revenue by Region (2016-2021) & (US$ Million)
Table 75. Asia Pacific Transmucosal Drug Delivery Devices Revenue Market Share by Region (2016-2021)
Table 76. Europe Transmucosal Drug Delivery Devices Sales by Country (2016-2021) & (K Units)
Table 77. Europe Transmucosal Drug Delivery Devices Sales Market Share by Country (2016-2021)
Table 78. Europe Transmucosal Drug Delivery Devices Revenue by Country (2016-2021) & (US$ Million)
Table 79. Europe Transmucosal Drug Delivery Devices Revenue Market Share by Country (2016-2021)
Table 80. Latin America Transmucosal Drug Delivery Devices Sales by Country (2016-2021) & (K Units)
Table 81. Latin America Transmucosal Drug Delivery Devices Sales Market Share by Country (2016-2021)
Table 82. Latin Americaa Transmucosal Drug Delivery Devices Revenue by Country (2016-2021) & (US$ Million)
Table 83. Latin America Transmucosal Drug Delivery Devices Revenue Market Share by Country (2016-2021)
Table 84. Middle East and Africa Transmucosal Drug Delivery Devices Sales by Country (2016-2021) & (K Units)
Table 85. Middle East and Africa Transmucosal Drug Delivery Devices Sales Market Share by Country (2016-2021)
Table 86. Middle East and Africa Transmucosal Drug Delivery Devices Revenue by Country (2016-2021) & (US$ Million)
Table 87. Middle East and Africa Transmucosal Drug Delivery Devices Revenue Market Share by Country (2016-2021)
Table 88. Allergan Corporation Information
Table 89. Allergan Description and Business Overview
Table 90. Allergan Transmucosal Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 91. Allergan Transmucosal Drug Delivery Devices Product
Table 92. Allergan Recent Development
Table 93. Amphastar Pharmaceuticals Inc Corporation Information
Table 94. Amphastar Pharmaceuticals Inc Description and Business Overview
Table 95. Amphastar Pharmaceuticals Inc Transmucosal Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 96. Amphastar Pharmaceuticals Inc Product
Table 97. Amphastar Pharmaceuticals Inc Recent Development
Table 98. Aquestive Therapeutics Inc Corporation Information
Table 99. Aquestive Therapeutics Inc Description and Business Overview
Table 100. Aquestive Therapeutics Inc Transmucosal Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 101. Aquestive Therapeutics Inc Product
Table 102. Aquestive Therapeutics Inc Recent Development
Table 103. ARS Pharmaceuticals Corporation Information
Table 104. ARS Pharmaceuticals Description and Business Overview
Table 105. ARS Pharmaceuticals Transmucosal Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 106. ARS Pharmaceuticals Product
Table 107. ARS Pharmaceuticals Recent Development
Table 108. Combinent BioMedical Systems Inc Corporation Information
Table 109. Combinent BioMedical Systems Inc Description and Business Overview
Table 110. Combinent BioMedical Systems Inc Transmucosal Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 111. Combinent BioMedical Systems Inc Product
Table 112. Combinent BioMedical Systems Inc Recent Development
Table 113. Aegis Therapeutics LLC Corporation Information
Table 114. Aegis Therapeutics LLC Description and Business Overview
Table 115. Aegis Therapeutics LLC Transmucosal Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 116. Aegis Therapeutics LLC Product
Table 117. Aegis Therapeutics LLC Recent Development
Table 118. Bespak Europe Ltd Corporation Information
Table 119. Bespak Europe Ltd Description and Business Overview
Table 120. Bespak Europe Ltd Transmucosal Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 121. Bespak Europe Ltd Product
Table 122. Bespak Europe Ltd Recent Development
Table 123. Callitas Therapeutics Inc Corporation Information
Table 124. Callitas Therapeutics Inc Description and Business Overview
Table 125. Callitas Therapeutics Inc Transmucosal Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 126. Callitas Therapeutics Inc Product
Table 127. Callitas Therapeutics Inc Recent Development
Table 128. Transmucosal Drug Delivery Devices Market Trends
Table 129. Transmucosal Drug Delivery Devices Market Drivers
Table 130. Transmucosal Drug Delivery Devices Market Challenges
Table 131. Transmucosal Drug Delivery Devices Market Restraints
Table 132. Transmucosal Drug Delivery Devices Customers List
Table 133. Transmucosal Drug Delivery Devices Distributors List
Table 134. Research Programs/Design for This Report
Table 135. Key Data Information from Secondary Sources
Table 136. Key Data Information from Primary Sources
List of Figures
Figure 1. Transmucosal Drug Delivery Devices Product Picture
Figure 2. Global Transmucosal Drug Delivery Devices Sales Market Share by Type in 2020 & 2027
Figure 3. Buccal Route Product Picture
Figure 4. Rectal Route Product Picture
Figure 5. Nasal Route Product Picture
Figure 6. Global Transmucosal Drug Delivery Devices Sales Market Share by Application in 2020 & 2027
Figure 7. Hospital
Figure 8. Residential
Figure 9. Transmucosal Drug Delivery Devices Report Years Considered
Figure 10. Global Transmucosal Drug Delivery Devices Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Transmucosal Drug Delivery Devices Market Size 2016-2027 (US$ Million)
Figure 12. Global Transmucosal Drug Delivery Devices Sales 2016-2027 (K Units)
Figure 13. Global Transmucosal Drug Delivery Devices Market Size Market Share by Region: 2021 Versus 2027
Figure 14. Global Transmucosal Drug Delivery Devices Sales Market Share by Region (2016-2021)
Figure 15. Global Transmucosal Drug Delivery Devices Sales Market Share by Region in 2020
Figure 16. Global Transmucosal Drug Delivery Devices Revenue Market Share by Region (2016-2021)
Figure 17. Global Transmucosal Drug Delivery Devices Revenue Market Share by Region in 2020
Figure 18. Global Transmucosal Drug Delivery Devices Sales Share by Manufacturer in 2020
Figure 19. The Top 10 and 5 Players Market Share by Transmucosal Drug Delivery Devices Revenue in 2020
Figure 20. Transmucosal Drug Delivery Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 21. Global Transmucosal Drug Delivery Devices Sales Market Share by Type (2016-2021)
Figure 22. Global Transmucosal Drug Delivery Devices Sales Market Share by Type in 2020
Figure 23. Global Transmucosal Drug Delivery Devices Revenue Market Share by Type (2016-2021)
Figure 24. Global Transmucosal Drug Delivery Devices Revenue Market Share by Type in 2020
Figure 25. Global Transmucosal Drug Delivery Devices Sales Market Share by Application (2016-2021)
Figure 26. Global Transmucosal Drug Delivery Devices Sales Market Share by Application in 2020
Figure 27. Global Transmucosal Drug Delivery Devices Revenue Market Share by Application (2016-2021)
Figure 28. Global Transmucosal Drug Delivery Devices Revenue Market Share by Application in 2020
Figure 29. United States Transmucosal Drug Delivery Devices Sales Growth Rate 2016-2027 (K Units)
Figure 30. United States Transmucosal Drug Delivery Devices Revenue Growth Rate 2016-2027 (US$ Million)
Figure 31. United States Transmucosal Drug Delivery Devices Market Share in Global Market 2016-2027
Figure 32. United States 5 and 10 Largest Transmucosal Drug Delivery Devices Players Market Share by Revenue in Transmucosal Drug Delivery Devices in 2020
Figure 33. United States Transmucosal Drug Delivery Devices Revenue Share by Type (2016-2021)
Figure 34. United States Transmucosal Drug Delivery Devices Revenue Growth Rate by Type in 2016 & 2020
Figure 35. United States Transmucosal Drug Delivery Devices Revenue Share by Application (2016-2021)
Figure 36. United States Transmucosal Drug Delivery Devices Revenue Growth Rate by Application in 2016 & 2020
Figure 37. North America Transmucosal Drug Delivery Devices Sales Growth Rate 2016-2021 (K Units)
Figure 38. North America Transmucosal Drug Delivery Devices Revenue Growth Rate 2016-2021 (US$ Million)
Figure 39. North America Transmucosal Drug Delivery Devices Sales Market Share by Country in 2020
Figure 40. North America Transmucosal Drug Delivery Devices Revenue Market Share by Country in 2020
Figure 41. U.S. Transmucosal Drug Delivery Devices Sales Growth Rate (2016-2021) (K Units)
Figure 42. U.S. Transmucosal Drug Delivery Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Canada Transmucosal Drug Delivery Devices Sales Growth Rate (2016-2021) (K Units)
Figure 44. Canada Transmucosal Drug Delivery Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Europe Transmucosal Drug Delivery Devices Sales Growth Rate 2016-2021 (K Units)
Figure 46. Europe Transmucosal Drug Delivery Devices Revenue Growth Rate 2016-2021 (US$ Million)
Figure 47. Europe Transmucosal Drug Delivery Devices Sales Market Share by Country in 2020
Figure 48. Europe Transmucosal Drug Delivery Devices Revenue Market Share by Country in 2020
Figure 49. Germany Transmucosal Drug Delivery Devices Sales Growth Rate (2016-2021) (K Units)
Figure 50. Germany Transmucosal Drug Delivery Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 51. France Transmucosal Drug Delivery Devices Sales Growth Rate (2016-2021) (K Units)
Figure 52. France Transmucosal Drug Delivery Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 53. U.K. Transmucosal Drug Delivery Devices Sales Growth Rate (2016-2021) (K Units)
Figure 54. U.K. Transmucosal Drug Delivery Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 55. Italy Transmucosal Drug Delivery Devices Sales Growth Rate (2016-2021) (K Units)
Figure 56. Italy Transmucosal Drug Delivery Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 57. Russia Transmucosal Drug Delivery Devices Sales Growth Rate (2016-2021) (K Units)
Figure 58. Russia Transmucosal Drug Delivery Devices Revenue Growth Rate (2016-2021) (US$ Million)
Figure 59.
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs